News
AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced ...
When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...
AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...
2d
NDTV Profit on MSNAstraZeneca sets up ₹166 cr Global Hub to boost AI driven healthcareGlobal bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 ...
Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 ...
This was the ADR's second consecutive day of losses.
3don MSN
The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...
AstraZeneca has started the process to improve its cancer treatment capabilities with an addition to its campus in southwest ...
Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...
Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating ...
AstraZeneca invests Rs 166 crore in a new Bengaluru Global Hub focused on AI-driven healthcare solutions, creating 400 new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results